Table 1:
Demographic characteristics | |
Mean age (SD) | 44.1 (17.0) |
Female gender | 107 (78.1%) |
Clinical characteristics | N (%) |
IBS subtype | |
IBS-D | 38 (27.7) |
IBS-C | 69 (50.4) |
IBS-M | 30 (21.9) |
Mean IBS symptom severity* | 266.1 (100.9) |
Baseline characteristics** | N (%) |
Anxiety | 48 (35) |
Depression | 23 (16.8) |
Sleep disturbance | 35 (25.6) |
Prior gastroenterology consultation | 107 (78.1) |
Duration of symptoms | |
< 1 year | 16 (11.7) |
1–5 years | 27 (19.7) |
5–10 years | 17 (12.4) |
>10 years | 77 (56.2) |
Healthcare utilization in three months after initial consultation | |
Serological or stool investigations performed | 76 (55.5) |
Median number of diagnostic tests performed*** | 1 (0–4) |
Median number of medications taking for their GI symptoms**** | 2 (0–10) |
Median number of recommendations at initial visit***** | 4 (1–10) |
Median number of phone calls | 0 (0–9) |
Median number of follow-up visits | 1 (0–4) |
Median number of services referred to | 0 (0–2) |
Physician characteristics | |
Patients evaluated by female physician | 101(73.7) |
Patients evaluated by Fellows at first visit | 51 (37.2) |
Mean values are expressed with standard deviation (SD) and median values with range.
Measured using IBS-SSS
Defined by PROMIS T-score ≥60
Includes endoscopies, manometries, breath tests, and radiologic investigations
Includes over the counter as well as prescription
Includes pharmacological and non-pharmacological therapies, referrals, lifestyle changes